Connor Susan C, Hodson Mark P, Ringeissen Stephanie, Sweatman Brian C, McGill Paul J, Waterfield Catherine J, Haselden John N
Safety Assessment, GlaxoSmithKline, Park Road, Ware, Hertfordshire, Herts SG12 0DP, UK.
Biomarkers. 2004 Jul-Oct;9(4-5):364-85. doi: 10.1080/13547500400006005.
A previous report of this work (Ringeissen et al. 2003) described the use of nuclear magnetic resonance (NMR) spectroscopy coupled with multivariate statistical data analysis (MVDA) to identify novel biomarkers of peroxisome proliferation (PP) in Wistar Han rats. Two potential biomarkers of peroxisome proliferation in the rat were described, N-methylnicotinamide (NMN) and N-methyl-4-pyridone-3-carboxamide (4PY). The inference from these results was that the tryptophan-nicotinamide adenine dinucleotide (NAD(+)) pathway was altered in correlation with peroxisome proliferation, a hypothesis subsequently confirmed by TaqMan analysis of the relevant genes encoding two key enzymes in the pathway, aminocarboxymuconate-semialdehyde decarboxylase (EC 4.1.1.45) and quinolinate phosphoribosyltransferase (EC 2.4.2.19). The objective of the present study was to investigate these data further and identify other metabolites in the NMR spectrum correlating equally with PP. MVDA Partial Least Squares (PLS) models were constructed that provided a better prediction of PP in Wistar Han rats than levels of 4PY and NMN alone. The resulting Wistar Han rat predictive models were then used to predict PP in a test group of Sprague Dawley rats following administration of fenofibrate. The models predicted the presence or absence of PP (above on arbitrary threshold of >2-fold mean control) in all Sprague Dawley rats in the test group.
此前关于这项工作的一份报告(林盖森等人,2003年)描述了如何使用核磁共振(NMR)光谱技术结合多变量统计数据分析(MVDA)来鉴定Wistar Han大鼠中过氧化物酶体增殖(PP)的新型生物标志物。报告描述了大鼠中过氧化物酶体增殖的两种潜在生物标志物,即N-甲基烟酰胺(NMN)和N-甲基-4-吡啶酮-3-甲酰胺(4PY)。从这些结果得出的推论是,色氨酸-烟酰胺腺嘌呤二核苷酸(NAD(+))途径与过氧化物酶体增殖相关发生了改变,这一假设随后通过对该途径中编码两种关键酶的相关基因进行TaqMan分析得到了证实,这两种关键酶分别是氨基羧基粘康酸半醛脱羧酶(EC 4.1.1.45)和喹啉酸磷酸核糖基转移酶(EC 2.4.2.19)。本研究的目的是进一步研究这些数据,并在NMR光谱中鉴定出与PP同样相关的其他代谢物。构建了MVDA偏最小二乘法(PLS)模型,该模型对Wistar Han大鼠中PP的预测能力优于单独使用4PY和NMN的水平。然后,将所得的Wistar Han大鼠预测模型用于预测给予非诺贝特后Sprague Dawley大鼠测试组中的PP情况。这些模型预测了测试组中所有Sprague Dawley大鼠是否存在PP(高于任意阈值>平均对照值的2倍)。